Drug Topics
JUNE 21, 2023
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Pharmacy Times
JUNE 21, 2023
Antibiotics that were found to be most commonly associated with clostridium difficile infection are piperacillin/tazobactam, meropenem, vancomycin, ciprofloxacin, ceftriaxone, and levofloxacin, according to a recent study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 21, 2023
Beauty and household items topped the list of what customers want to buy in the pharmacy.
Pharmacy Times
JUNE 21, 2023
Among health care professionals, pharmacists are best suited to serve as trusted partners for patients to help ensure they understand their medication regimen, identify medication-related problems, and work with prescribers to close gaps in care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 21, 2023
For years, public health guidance about opioid overdoses has been relatively simple: Administer naloxone , then call 911. But the days of simply spraying naloxone into an overdose victim’s nose, then watching that person resume breathing and wake up within minutes, are over.
Drug Topics
JUNE 21, 2023
The first RSV vaccines were approved by the FDA earlier this year.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 21, 2023
Last year, after a string of high-profile trial failures , the Huntington’s disease community got positive news in the form of very early data from an experimental gene therapy for the rare neurodegenerative condition. On Wednesday, however, the company behind the drug released updated figures that were more mixed — even befuddling. The study from Uniqure, a Dutch biotech, randomized early stage Huntington’s patients to receive low-dose treatment, a high-dose treatment, or a
Fierce Healthcare
JUNE 21, 2023
Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC. | Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC.
Pharmacy Times
JUNE 21, 2023
Novavax announced the development of a protein-based monovalent XBB COVID-19 vaccine with the intention of it being manufactured and available for the fall vaccination campaign.
Fierce Healthcare
JUNE 21, 2023
The southeastern region of the U.S. | The southeastern region of the U.S. scored worst across the board in the Commonwealth Fund’s annual scorecard on states' healthcare system performance.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
European Pharmaceutical Review
JUNE 21, 2023
The US Food and Drug Administration (FDA) has approved LODOCO ® , the “first drug to target cardiovascular inflammation,” reported Dr Paul Ridker, MPH, Professor of medicine at Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital. It is the first anti-inflammatory cardiovascular treatment demonstrated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adults with establ
Pharmacy Times
JUNE 21, 2023
Jardiance and Synjardy approved as an addition to diet and exercise to improve blood sugar control in children aged 10 years and older with type 2 diabetes.
STAT
JUNE 21, 2023
The rat kidney was peculiarly beautiful — an edgeless viscera about the size of a quarter, gemstone-like and gleaming as if encased in pure glass. It owed its veneer to a frosty, minus 150-degree Celsius plunge into liquid nitrogen, a process known as vitrification, that shocked the kidney into an icy state of suspended animation. Then researchers at the University of Minnesota restarted the kidney’s biological clock, rewarming it before transplanting it back into a live rat ȁ
Drug Topics
JUNE 21, 2023
Lodoco (colchicine) approval was based on a clinical trial with 5,522 patients with chronic coronary disease, which was published in Circulation in February 2022.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
JUNE 21, 2023
After Merck and Bristol Myers Squibb took shots at the Inflation Reduction Act (IRA) in separate lawsuits, influential trade group Pharmaceutical Research and Manufacturers of America (PhRMA)—plus | Trade group PhRMA is the latest to go after the IRA in a lawsuit claiming violations of the Fifth and Eighth amendments. The suit follows similar legal efforts by Merck and Bristol Myers Squibb.
STAT
JUNE 21, 2023
Elle Brooks-Tao, a filmmaker, got thrust into the confusing world of Lyme disease when a family member became infected and had debilitating symptoms for over eight years before being diagnosed. The reported cases of tick-borne illnesses like Lyme in the U.S. had risen “to a scary degree” she said. Even more alarming was learning it was possible to transmit spirochetes — bacteria that cause Lyme and other diseases — from a mother to a fetus through the placenta.
Fierce Pharma
JUNE 21, 2023
The PARP inhibitor class is welcoming its second FDA approval in prostate cancer in the span of several weeks. The new approval, for Pfizer, is broader than the first but still limited. | The PARP inhibitor class is welcoming its second FDA approval in prostate cancer in the span of several weeks. The new approval, for Pfizer, is broader than the first but still limited.
Pharmacy Times
JUNE 21, 2023
Migraines can be a primary diagnosis or a symptom of an underlying medical or psychological condition.
STAT
JUNE 21, 2023
The horror stories of Black women dying or coming close to death in childbirth never seem to stop coming. The most recent headlines have been about the tragic case of three-time Olympian Tori Bowie , who died in her home from childbirth complications. Her teammate Tianna Madison wrote on Instagram , “THREE (3) of the FOUR (4) of us who ran on the SECOND fastest 4x100m relay of all time, the 2016 Olympic Champions have nearly died or died in childbirth.
Pharmaceutical Technology
JUNE 21, 2023
AGEPHA Pharma has received approval from the US Food and Drug Administration (FDA) for LODOCO (colchicine, 0.5 mg tablet) to treat cardiovascular disease. LODOCO is indicated for reducing the risk of stroke, myocardial infarction and cardiovascular death in adults with established atherosclerotic cardiovascular disease (ASCVD) or with multiple risk factors for the disease.
STAT
JUNE 21, 2023
Drug middlemen once again were on the hot seat at a congressional hearing on Wednesday. The hearing by the House Education and Workforce health subcommittee was about consolidation in the hospital and health insurance sectors. No hospital or insurance company representatives testified, but JC Scott, president of the pharmacy benefit manager lobbying group Pharmaceutical Care Management Association was tapped as a witness.
Fierce Pharma
JUNE 21, 2023
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will vote this afternoon on recommendations for the use of new respiratory syncytial virus (RSV) | The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will vote this afternoon on recommendations for the use of new RSV shots from GSK and Pfizer.
STAT
JUNE 21, 2023
The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients. A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.
Fierce Pharma
JUNE 21, 2023
Merck is back home again in Rahway, New Jersey, at the site that it established 90 years ago as Merck Research Laboratories. | Merck is back home again in Rahway, New Jersey, at the site that it established 90 years ago as Merck Research Laboratories. After being headquartered for eight years, seven miles to the north in Kenilworth, and before that, for 23 years in Whitehouse Station, 35 miles to the west, Merck has returned to its “reimagined” Rahway facility.
STAT
JUNE 21, 2023
A genomic test for the human papillomavirus has shown promise in early-stage trials, raising hopes that it could bolster cervical cancer screening among women living in sub-Saharan Africa, the region with the highest rates of cervical cancer deaths worldwide. The trials were documented in a study , published Wednesday in Science Translational Medicine, led by researchers from Rice University.
pharmaphorum
JUNE 21, 2023
Pharmaphorum Editor-in-Chief Jonah Comstock spoke with Jennifer Elliott, global solid tumour lead at Takeda, about the company’s Fruquintinib product in late-stage metastatic colorectal cancer, in-licensed from HUTCHMED, and how it could provide new hope for patients with few options.
STAT
JUNE 21, 2023
A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations opted Wednesday not to recommend that all seniors get a vaccine to protect against RSV. Instead, the Advisory Committee on Immunization Practices said that anyone 60 and older should be able to get one of the new vaccines — being brought to market by GSK and Pfizer — if they and their physicians think it would be worthwhile.
Pharmacy Times
JUNE 21, 2023
Mama Village Rx & Wellness cares for Mamaroneck community, owner considers patients like family.
STAT
JUNE 21, 2023
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. But does the system work for patients? And how can we fix it when it doesn’t?
Drug Topics
JUNE 21, 2023
According to the FDA, the approvals “provide a new class of medicines taken by mouth to treat pediatric T2D.
STAT
JUNE 21, 2023
BRUSSELS — Leaders of European pharmaceutical companies on Wednesday said that a proposed overhaul of the E.U.’s medicines policies could render the region’s industry less competitive, the latest step in their opposition to legislation that could shorten the exclusivity period they have to sell their drugs. “A competitive industry will play a key role in a healthier Europe,” Novo Nordisk CEO Lars Fruergaard Jørgensen said at a press briefing held by
Drug Store News
JUNE 21, 2023
The supplement is designed to increase resting energy metabolism while reducing body fat, abdominal fat, waist size and visible cellulite, the company said.
STAT
JUNE 21, 2023
It’s been nearly a year since Congress passed the Inflation Reduction Act, raising a chorus of drug executive and investor complaints that it would decimate the development of small-molecule medicines. After all, it opens the door for Medicare to negotiate the price of small-molecule drugs after nine years on the market (as opposed to 13 years for biologic drugs like vaccines, cell therapies, or gene therapies).
Drug Store News
JUNE 21, 2023
Target is testing an extension facility that helps it get online orders to more shoppers the day after they buy.
Expert insights. Personalized for you.
183 
Let's personalize your content